Pinnacle Wealth Management Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Pinnacle Wealth Management Advisory Group's VRTX Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group increased its Vertex Pharmaceuticals (VRTX) stake by 43% in Q2 2026, buying an estimated $166K and bringing the position to 1,248 shares worth $620K. The position accounts for 0.04% of the portfolio, ranked #245.

Pinnacle Wealth Management Advisory Group first reported a position in VRTX in Q1 2023 and has held it in 14 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Pinnacle Wealth Management Advisory Group held 1,248 shares of Vertex Pharmaceuticals worth $620K as of Q2 2026.
• Pinnacle Wealth Management Advisory Group bought 374 Vertex Pharmaceuticals shares in Q2 2026, an estimated $166K.
• Vertex Pharmaceuticals made up 0.04% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #245 holding.
• Pinnacle Wealth Management Advisory Group first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
• 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.